An experimental vaccine against kidney cancer has shown promising results in reducing the recurrence of the disease, German researchers said on Friday. Kidney cancer occurs mostly in adults over 40 and accounts for about three percent of all cancers. About 32,000 new cases are diagnosed each year in the United States alone.
